Hai Zheng Pharmaceutical and Sinopharm Signed Strategic Cooperation Agreement on Retail Project

January 23, 2024  Source: drugdu 74

"/

Hai Zheng Pharmaceutical (hereinafter referred to as "Hai Zheng Pharmaceutical") signed a strategic cooperation agreement on retail project with Sinopharm Holdings Corporation (hereinafter referred to as "Sinopharm") in Shanghai. (hereinafter referred to as "Sinopharm") signed a strategic cooperation agreement on retail project in Shanghai, both parties will carry out in-depth cooperation in healthcare and retail channels, through the integration of the advantageous resources of both parties to maximize the synergistic effect, and to bring more personalized, convenient and efficient drug purchasing experience for the majority of patients to improve the level of service.

At the meeting, HANHUI Pharmaceutical and Guozhong Quanzai introduced the company profiles and project plans of the two sides respectively, and launched in-depth exchanges and discussions on the strategic cooperation of the two sides' retail projects. Chairman Shen Xinghu and his entourage also visited the corporate showroom in Sinopharm Building to understand the development history, business innovation and strategic layout of Sinopharm. Chairman Shen Xinghu highly recognized the historical development of Sinopharm and the value of the company, and looked forward to more comprehensive, deeper and broader business cooperation with Sinopharm.

The strategic cooperation of the retail project marks the beginning of a new chapter of deepening cooperation and win-win empowerment between CNMC and Hanhui Pharmaceutical, which will work together to actively explore healthcare innovations, take patients' needs and interests as the starting point, comprehensively enhance patients' accessibility to medicines with new technologies, methods and modes, and provide more professional and higher-quality medical and healthcare services.

 

Source: https://mp.weixin.qq.com/s/XpDJkWZJCaPboWFH1B7Tkg

By editor
Share: 

your submission has already been received.

OK

Subscribe

Please enter a valid Email address!

Submit

The most relevant industry news & insight will be sent to you every two weeks.